TXG
10x Genomics, Inc. · Healthcare · Medical - Healthcare Information Services
动量输入（同类管理人）：
持有人广度 -9.5% ·
股份流向 -0.5% ·
净新建仓位 -15.8%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 153.99K | $11.76M | n/a | n/a |
| Q2 2026 | 113 | +6 | 98.93M | $3.79B | +15 | −8 |
| Q1 2026 | 109 | +3 | 94.02M | $1.99B | +12 | −10 |
| Q4 2025 | 107 | +3 | 97.86M | $1.59B | +4 | n/a |
| Q3 2025 | 19 | -2 | 71.88M | $839.83M | n/a | −3 |
| Q2 2025 | 19 | +1 | 64.66M | $748.72M | +2 | −1 |
| Q1 2025 | 15 | 0 | 30.56M | $266.82M | +1 | −1 |
| Q4 2024 | 15 | +1 | 24.83M | $356.61M | +3 | −2 |
| Q3 2024 | 13 | 0 | 22.71M | $512.82M | +1 | −1 |
| Q2 2024 | 13 | n/a | 21.07M | $409.76M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 13.27M | +6.7% | $155.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | ARK Investment Management ✦ | 11.89M | -14.4% | $138.96M | 0.8% | ▼ Trim | 6 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 9.46M | +0.3% | $110.59M | 0.0% | ▲ Add | 2 | SEC ↗ ×17 |
| 4 | Fidelity (FMR) ✦ | 8.46M | -6.0% | $98.87M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 5 | Millennium Management ✦ | 5.44M | +88.6% | $63.57M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.29M | +126.6% | $50.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 7 | Morgan Stanley ✦ | 2.82M | n/a | $32.93M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 8 | Geode Capital Management ✦ (被动) | 2.71M | +2.3% | $31.70M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 2.73M | -34.1% | $31.47M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 10 | Goldman Sachs Group ✦ | 2.68M | n/a | $31.27M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | State Street Global Advisors ✦ (被动) | 2.52M | +1.1% | $29.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 2.15M | n/a | $25.11M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 13 | Capital World Investors ✦ | 1.45M | 0.0% | $16.98M | 0.0% | Held | 6 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 1.04M | -29.0% | $12.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 591.39K | -42.4% | $6.91M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 162.91K | -78.2% | $1.90M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 152.83K | -43.6% | $1.79M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Marshall Wace ✦ | 51.00K | -87.2% | $596,178 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Gotham Asset Management ✦ | 18.93K | -75.3% | $221,315 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Citadel Advisors | $2.27M | 曾为 0.0% |
| Arrowstreet Capital | $1.43M | 曾为 0.0% |
| Norges Bank | $841,565 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 328 持有人, 124.40M 股份, $2.59B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 1.00K 股 · $78,228
Director · 1.22K 股 · $100,542
Director · 2.27K 股 · $185,391
Director · 1.32K 股 · $107,082
Director · 614 股 · $48,820
Director · 292 股 · $22,833
Officer, Director · 2.80K 股 · $230,622
Officer, Director · 9.90K 股 · $810,071
Officer, Director · 9.30K 股 · $752,401
Officer, Director · 2.00K 股 · $159,239
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论